Oxidation as "The Stress of Life"

Aging

Volumn 3, Issue 9, 2011, Pages 906-910

  Malinin, Nikolay L ^a   West, Xiaoxia Z ^a   Byzova, Tatiana V ^a  

^a JACOBS ENGINEERING   (United States)

Author keywords

Aging; AMD; Angiogenesis; Atherosclerosis; Lipid oxidation; Oxidative stress; Toll like receptor 2

Indexed keywords

PHOSPHOLIPID; PYRROLE DERIVATIVE; TOLL LIKE RECEPTOR;

AGING; ANGIOGENESIS; ANIMAL; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW;

AGING; ANIMALS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHOLIPIDS; PYRROLES; TOLL-LIKE RECEPTORS;

EID: 84856667720     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100385     Document Type: Article

References (46)

1. Stadtman ER. Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci. 2001; 928:22-38.
2. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956; 11:298-300.
3. Nystrom T. Role of oxidative carbonylation in protein quality control and senescence. EMBO J. 2005; 24:1311-1317.
4. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res. 2011; 711:193-201.
5. Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011; 21:103-115.
6. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2010; 469:221-225.
7. Carey J, Judge D. Longevity Records - Life Spans of Mammals, Birds, Amphibians, Reptiles, and Fish: University Press of Southern Denmark; 2000.
8. Yang W, Hekimi S. A mitochondrial superoxide signal triggers increased longevity in Caenorhabditis elegans. PLoS Biol. 2010;8(12):1-14.
9. Lee SJ, Hwang AB, Kenyon C. Inhibition of respiration extends C. elegans life span via reactive oxygen species that increase HIF- 1 activity. Curr Biol. 2010; 20:2131-2136.
10. Haigis MC, Yankner BA. The aging stress response. Mol Cell. 2010; 40:333-344.
11. Zuin A, Castellano-Esteve D, Ayte J, Hidalgo E. Living on the edge: stress and activation of stress responses promote lifespan extension. Aging (Albany NY). 2010; 2:231-237.
12. Blagosklonny MV. Aging: ROS or TOR. Cell Cycle. 2008; 7:3344-3354.
13. Pani G. P66SHC and ageing: ROS and TOR? Aging (Albany NY). 2010; 2:514-518.
14. Lang F, Lang KS, Lang PA, Huber SM, Wieder T. Mechanisms and significance of eryptosis. Antioxid Redox Signal. 2006; 8:1183-1192.
15. Erusalimsky JD. Vascular endothelial senescence: from mechanisms to pathophysiology. J Appl Physiol. 2009; 106:326-332.
16. Lakatta EG, Wang M, Najjar SS. Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels. Med Clin North Am. 2009; 93:583-604, Table of Contents.
17. Nicolakakis N, Hamel E. Neurovascular function in Alzheimer's disease patients and experimental models. J Cereb Blood Flow Metab. 2011; 31:1354-1370.
18. Neumann HA, Berretty PJ, Folmer SC, Cormane RH. Hepatitis B surface antigen deposition in the blood vessel walls of urticarial lesions in acute hepatitis B. Br J Dermatol. 1981; 104:383-388.
19. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001; 357:539-545.
20. Niethammer P, Grabher C, Look AT, Mitchison TJ. A tissuescale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature. 2009; 459:996-999.
21. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004; 7:97-110.
22. West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, Borden EC, Podrez EA, Salomon RG, Byzova TV. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature. 2010; 467:972-976.
23. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A. 2002; 99:14682-14687.
24. Ebrahem Q, Renganathan K, Sears J, Vasanji A, Gu X, Lu L, Salomon RG, Crabb JW, Anand-Apte B. Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration. Proc Natl Acad Sci U S A. 2006; 103:13480-13484.
25. Courtois Y. The role of CD36 receptor in the phagocytosis of oxidized lipids and AMD. Aging (Albany NY). 2010; 2:888-889.
26. Picard E, Houssier M, Bujold K, Sapieha P, Lubell W, Dorfman A, Racine J, Hardy P, Febbraio M, Lachapelle P, et al. CD36 plays an important role in the clearance of oxLDL and associated agedependent sub-retinal deposits. Aging (Albany NY). 2010; 2:981-989.
27. Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997; 388:394-397.
28. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol. 2008; 8:279-289.
29. Srikrishna G, Freeze HH. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia. 2009; 11:615-628.
30. Grote K, Schuett H, Salguero G, Grothusen C, Jagielska J, Drexler H, Muhlradt PF, Schieffer B. Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration. Blood. 2010; 115:2543-2552.
31. Hong S, Van Kaer L. Immune privilege: keeping an eye on natural killer T cells. J Exp Med. 1999; 190:1197-1200.
32. Ebos JM, Kerbel RS. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol. 2011;8(4):210-221.
33. Spirig R, Djafarzadeh S, Regueira T, Shaw SG, von Garnier C, Takala J, Jakob SM, Rieben R, Lepper PM. Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions. PLoS One. 2010; 5:e0010983.
34. Ousset M, Bouquet F, Fallone F, Biard D, Dray C, Valet P, Salles B, Muller C. Loss of ATM positively regulates the expression of hypoxia inducible factor 1 (HIF-1) through oxidative stress: Role in the physiopathology of the disease. Cell Cycle. 2010; 9:2814-2822.
35. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, et al. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the quot;reverse Warburg effectquot;: a transcriptional informatics analysis with validation. Cell Cycle. 2010; 9:2201-2219.
36. Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, Whitaker-Menezes D, Daumer KM, Lin Z, Witkiewicz AK, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle. 2010; 9:3256-3276.
37. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG. Toll-like receptor 2- mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol. 2000; 1:533-540.
38. Jun JI, Lau LF. Cellular senescence controls fibrosis in wound healing. Aging (Albany NY). 2010; 2:627-631.
39. Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, Albuquerque RJ, Yamasaki S, Itaya M, Pan Y, et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature. 2008; 452:591-597.
40. Tseng PH, Matsuzawa A, Zhang W, Mino T, Vignali DA, Karin M. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat Immunol. 2010; 11:70-75.
41. Burdelya LG, Krivokrysenko VI, Tallant TC, Strom E, Gleiberman AS, Gupta D, Kurnasov OV, Fort FL, Osterman AL, Didonato JA, et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science. 2008; 320:226-230.
42. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, Thorne PS, Wills-Karp M, Gioannini TL, Weiss JP, et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature. 2009; 457:585-588.
43. Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science. 2007; 317:124-127.
44. Coste I, Le Corf K, Kfoury A, Hmitou I, Druillennec S, Hainaut P, Eychene A, Lebecque S, Renno T. Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation. J Clin Invest. 2010; 120:3663-3667.
45. Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest. 2005; 115:3149-3156.
46. Selye H. A Syndrome produced by Diverse Nocuous Agents Nature. 1936; 138:32.